Cardiovascular abnormalities in Klinefelter syndrome

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 754-759

  Pasquali, Daniela ^a   Arcopinto, Michele ^b   Renzullo, Andrea ^a   Rotondi, Mario ^c   Accardo, Giacomo ^a   Salzano, Andrea ^b   Esposito, Daniela ^a   Saldamarco, Lavinia ^b   Isidori, Andrea M ^e   Marra, Alberto M ^b   Ruvolo, Antonio ^b   Napoli, Raffaele ^b   Bossone, Eduardo ^d   Lenzi, Andrea ^e   Baliga, Ragavendra R ^f   Saccà, Luigi ^b   Cittadini, Antonio ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d IRCCS POLICLINICO SAN DONATO   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f OHIO STATE UNIVERSITY   (United States)

Author keywords

Cardiovascular abnormalities; Chronotropic incompetence; Heart; Klinefelter

Indexed keywords

TESTOSTERONE;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; ENDOTHELIUM; EXERCISE; EXERCISE TEST; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPOGONADISM; KLINEFELTER SYNDROME; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; VASODILATATION;

12-LEAD SCALAR ELECTROCARDIOGRAM; BLOOD PRESSURE; BMI; BODY MASS INDEX; BP; CARBON DIOXIDE PRODUCTION; CARDIO-PULMONARY EXERCISE TEST; CARDIOVASCULAR ABNORMALITIES; CHRONOTROPIC INCOMPETENCE; CI; CPET; ECG; FLOW-MEDIATED DILATION; FMD; HEART; HEART RATE; HEART RECOVERY RATE; HOMA; HOMEOSTASIS MODEL ASSESSMENT; HR; HRR; IMT; INTIMA-MEDIA THICKNESS; IRT; ISOVOLUMIC RELAXATION TIME; KLINEFELTER; KLINEFELTER SYNDROME; KS; LEFT VENTRICLE; LV; OXYGEN UPTAKE; TDI; TISSUE DOPPLER IMAGING; VCO(2); VE; VENTILATION PER MINUTE; VO(2);

ADULT; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; CARDIOVASCULAR ABNORMALITIES; CAROTID INTIMA-MEDIA THICKNESS; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE TEST; HUMANS; KLINEFELTER SYNDROME; MALE; POPULATION SURVEILLANCE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84885316766     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.09.215     Document Type: Article

References (47)

1. Klinefelter Jr HF, Reifenstein Jr EC, Albright F. Syndrome characterized by gynaecomastia, aspermatogenesis without A-Leydigism, and increased excretion of follicle stimulating hormone. J Clin Endocrinol Metab 1942;2:615-27.
2. Bojesen A, Juul S, Gravholt CH. Prenatal and postnatal prevalence of Klinfelter Syndrome: a national registry study. J Clin Endocrinol Metab 2003;88:622-6.
3. Bojesen A, Juul S, Birkebaek N, Gravholt CH. Increased mortality in Klinefelter syndrome. J Clin Endocrinol Metab 2004;89:3830-4.
4. Swerdlow AJ, Higgins CD, Schoemaker MJ, Wright AF, Jacobs PA, United Kingdom Clinical Cytogenetics Group. Mortality in patients with Klinefelter Syndrome in Britain: a cohort study. J Clin Endocrinol Metab 2005;90:6516-22.
5. Bojesen A, Gravholt CH. Morbidity and mortality in Klinefelter syndrome (47, XXY). Acta Paediatr 2011;100:807-13.
6. Bojesen A, Juul S, Birkebaek NH, Gravholt CH. Morbidity in Klinefelter syndrome: a Danish register study based on hospital discharge diagnoses. J Clin Endocrinol Metab 2006;91:1254-60.
7. Bojesen A, Kristensen K, Birkebaek NH, et al. The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care 2006;29:1591-8.
8. Andersen NH, Bojesen A, Kristensen K, et al. Left ventricular dysfunction in Klinefelter syndrome is associated to insulin resistance, abdominal adiposity and hypogonadism. Clin Endocrinol 2008;69:785-91.
9. Fricke GR, Mattern HJ, Schweikert HU, Schwanitz G. Klinefelter's syndrome and mitral valve prolapse. An echocardiographic study in twenty-two patients. Biomed Pharmacother 1984;38:88-97.
10. Fricke GR, Mattern HJ, Schweikert HU. Mitral valve prolapse in Klinefelter syndrome. Lancet 1981;26(2):1414.
11. Radicioni AF, De Marco E, Gianfrilli D, et al. Strategies and advantages of early diagnosis in Klinefelter's Syndrome. Mol Hum Reprod 2010;16:434-40.
12. Radicioni AF, Ferlin A, Balercia G, et al. Consensus statement on diagnosis and clinical management of Klinefelter Syndrome. J Endocrinol Invest 2010;33: 839-50.
13. Cittadini A, Napoli R, Monti MG, et al. Metformin prevents the development of chronic heart failure in the SHHF rat model. Diabetes 2012;61:944-53.
14. De Bellis A, Colao A, Savoia A, et al. Effect of long-term cabergoline therapy on the immunological pattern and pituitary function of patients with idiopathic hyperprolactinaemia positive for antipituitary antibodies. Clin Endocrinol 2008;69: 285-91.
15. Basciani S, Watanabe M, Mariani S, et al. Hypogonadism in a patient with two novel mutations of the luteinizing hormone β-subunit gene expressed in a compound heterozygous form. J Clin Endocrinol Metab 2012;97:3031-8.
16. Cittadini A, Ines Comi L, Longobardi S, et al. A preliminary randomized study of growth hormone administration in Becker and Duchenne muscular dystrophies. Eur Heart J 2003;24:664-72.
17. Yu CM, Sanderson JE, Marwick TH, Oh JK. Tissue Doppler imaging: a new prognosticator for cardiovascular diseases. J Am Coll Cardiol 2007;49:1903-14.
18. Oliviero U, Cittadini A, Bosso G, et al. Effects of long-term L-thyroxine treatment on endothelial function and arterial distensibility in young adults with congenital hypothyroidism. Eur J Endocrinol 2010;162:289-94.
19. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. J Am Coll Cardiol 2002;39:257-65.
20. Cittadini A, Saldamarco L, Marra AM, et al. Growth hormone deficiency in patients with chronic heart failure and beneficial effects of its correction. J Clin Endocrinol Metab 2009;94:3329-36.
21. Brubaker PH, Kitzman DW. Chronotropic incompetence: causes, consequences, and management. Circulation 2011;123:1010-20.
22. Cole CR, Foody JM, Blackstone EH, Lauer MS. Heart rate recovery after submaximal exercise testing as a predictor of mortality in a cardiovascularly healthy cohort. Ann Intern Med 2000;132:552-5.
23. Grundy SM, Brewer Jr HB, Cleeman JL, et al. Definition of metabolic syndrome: Report of the National Heart, Lung and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-8.
24. Mammi C, Calanchini M, Antelmi A, et al. Androgens and adipose tissue in males: a complex and reciprocal interplay. Int J Endocrinol 2012;2012:789653.
25. Carson III CC, Rosano G. Exogenous testosterone, cardiovascular events, and cardiovascular risk factors in elderly men: a review of trial data. J Sex Med 2012;9: 54-67.
26. Vitale C, Mendelsohn ME, Rosano GM. Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol 2009;6:532-42.
27. Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J 2011;32:670-9.
28. Fukuta H, Little WC. Contribution of systolic and diastolic abnormalities to heart failure with a normal and reduced ejection fraction. Progr Cardiovasc Dis 2007;49:229-40.
29. Lauer MS, Francis GS, Okin PM, Pashkow FJ, Snader CE, Marwick TH. Impaired chronotropic response to exercise stress testing as a predictor of mortality. JAMA 1999;281:524-9.
30. Higginbotham MB, Morris KG, Williams RS, McHale PA, Coleman RD, Cobb FR. Regulation of stroke volume during submaximal and maximal upright exercise in normal man. Circ Res 1986;58:281-91.
31. Higginbotham MB, Morris KG, Williams RS, Coleman RE, Cobb FR. Physiologic basis for the age-related decline in aerobic work capacity. Am J Cardiol 1986;57: 1374-9.
32. Lauer MS. Autonomic function and prognosis. Cleve Clin J Med 2009;76:S18-22.
33. Ingle L. Theoretical rationale and practical recommendations for cardiopulmonary exercise testing in patients with chronic heart failure. Heart Fail Rev 2007;12: 12-22.
34. Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness andmajor risk factors: the Atherosclerosis Risk in Communities (ARIC) Study. 1987-1993. Am J Epidemiol 1997;146:483-94.
35. Ebrahim S, Papacosta O, Whincup P, et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke 1999;30:841-50.
36. Zureik M, Touboul PJ, Bonithon-Kopp C, et al. Cross-sectional and 4-year longitudinal associations between brachial pulse pressure and common carotid intima-media thickness in a general population. The EVA study. Stroke 1999;30: 550-5.
37. Prati P, Vanuzzo D, Casaroli M, et al. Determinants of carotid plaque occurrence. A long-term prospective population study: the San Daniele Project. Cerebrovasc Dis 2006;22:416-22.
38. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997;96:1432-7.
39. Tsivgoulis G, Vemmos K, Papamichael C, et al. Common carotid artery intima-media thickness and the risk of stroke recurrence. Stroke 2006;37:1913-6.
40. Rosano GM, Sheiban I, Massaro R, et al. Low testosterone levels are associated with coronary artery disease in male patients with angina. Int J Impot Res 2007;19:176-82.
41. Rosano GM, Leonardo F, Pagnotta P, et al. Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation 1999;99:1666-70
42. [Erratum in: Circulation 2000; 10:584].
43. Polak JF, Pencina MJ, Pencina KM, O'Donnell CJ, Wolf PA, D'Agostino Sr RB. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med 2011;365:213-21.
44. Caminiti G, Volterrani M, Iellamo F, et al. Effect of long-lasting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance and baroreflex sensitivity in elderly patients with chronic heart failure: a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol 2009;54: 919-27.
45. Cornoldi A, Caminiti G, Marrazzi G, et al. Effects of chronic testosterone administration on myocardial ischemia, lipid metabolism and insulin resistance in elderly male diabetic patients with coronary artery disease. Int J Cardiol 2010;142:50-5.
46. Kaushik M, Sontineni SP, Hunter C. Cardiovascular disease and androgens: a review. Int J Cardiol 2010;142:8-14.
47. Bossone E, Limongelli G, Malizia G, et al. The T.O.S.CA. Project: research, education and care. Monaldi Arch Chest Dis 2011;76:198-203.